The Scientific Do-Over

What would you do if you could apply modern technologies to yesterday's scientific questions?

Written byJeffrey M. Perkel
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

I knew a number of gifted graduate students when I worked at the bench, but I never met one like Arul Chinnaiyan. His was an exceptionally productive graduate career: Between 1995 and 1998, Chinnaiyan and his advisor at the University of Michigan coauthored 16 papers, including two that describe the identification of apoptotic signaling pathway members, FADD and FLICE - work that has since been cited 1,415 and 2,026 times, respectively.

To identify FADD,1 Chinnaiyan, now the S.P. Hicks Endowed Professor of Pathology at Michigan, performed a yeast two-hybrid (Y2H) screen using the Fas cytoplasmic domain as the bait. "That was really the only reasonable discovery technology at the time to look for novel protein interactions," he says. The expedition paid off for Chinnaiyan, but as is so often the case when one goes fishing with Y2H, he reeled in a pile of red herrings, too. In all, he and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies